News

stock market IPO

Heartflow, known for its AI-based CCTA evaluations, appears to be going public. The news follows years of momentum for the California-based company, including improved Medicare reimbursements for cardiac CT and a new Category I CPT code for its Plaque Analysis software.

One of the study's most significant findings was that patients managed using the advanced AI software saw LDL cholesterol drops of 18.7 mg/dL, with a 15% reduction in their risk of a cardiac event. Even patients with no calcified plaque saw significant changes in care management.

Thumbnail

A heart team chose to perform BASILICA before valve-in-valve TAVR in a failed Lotus device to help minimize the risk of complications. These scenarios will likely grow more and more common as patients outlive their TAVR valves.

The American Heart Association (AHA) has launched a nationwide data-driven research competition to uncover how inflammation contributes to cardiovascular risk and how it is currently addressed in clinical practice. The initiative, called the Systemic Inflammation Data Challenge, invites data scientists, clinicians, and researchers to leverage advanced analytics and electronic medical record (EMR) data to better understand the impact of systemic inflammation on atherosclerotic cardiovascular disease.

Are care teams doing enough to take on inflammation? The American Heart Association hopes this new research initiative can help answer that question, and many others. 

Thumbnail

ICAD shareholders filed suit against the transaction last month in New York, claiming financial estimates used in the deal are misleading. 

radiology trends lungs imaging graphs

The Mobile Cancer Screening Act would offer grants to help imaging providers purchase mobile CT screening units through the federal government. 
 

Thumbnail

Human Longevity is a luxury clinic that's part of a “lucrative and growing industry” focused on preventive care. 

Trump AI summit in Pittsburgh

The numbers from Pittsburgh are staggering. And they’re all about blasting American-made AI into the stratosphere, if not to Infinity and beyond. 

Reports indicate that the 61-year-old male entered the room while an exam was being performed on a patient.

Philips Healthcare launched the Philips ECG AI Marketplace platform that gives cardiac care teams access to multiple vendor offerings in one central location to more efficiently manage and implement artificial intelligence (AI)-powered diagnostic tools through Philips ECG workstations.

Philips has launched a new 'AI Marketplace' that expands access to third-party diagnostic tools. The company's goal is to put a variety of offerings into one convenient location for clinicians.

Former American College of Cardiology (ACC) president Kim Allan Williams, Sr., MD, MACC, MASNC, FAHA, FESC, chair, department of medicine, University of Louisville School of Medicine, and an ACC delegate to the American Medical Association House of Delegates, discusses how cardiology should be focusing more on earlier prevention efforts in cardiology.

Former ACC president Kim Allan Williams Sr., MD, thinks cardiologists should be much more proactive. Encouraging healthy eating habits now, for example, can keep patients out of the hospital later in life and reduce healthcare spending.

doctor telehealth computer screen

Researchers with the Neiman Health Policy Institute recently investigated how COVID-related care site shifts impacted diagnostic radiology, sharing their findings in JACR

Around the web

Heartflow, known for its AI-based CCTA evaluations, appears to be going public. The news follows years of momentum for the California-based company, including improved Medicare reimbursements for cardiac CT and a new Category I CPT code for its Plaque Analysis software.

One of the study's most significant findings was that patients managed using the advanced AI software saw LDL cholesterol drops of 18.7 mg/dL, with a 15% reduction in their risk of a cardiac event. Even patients with no calcified plaque saw significant changes in care management.

A heart team chose to perform BASILICA before valve-in-valve TAVR in a failed Lotus device to help minimize the risk of complications. These scenarios will likely grow more and more common as patients outlive their TAVR valves.